These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 29858768)

  • 1. Influence of Gd-EOB-DTPA on T1 dependence of the proton density fat fraction using magnetic resonance spectroscopy.
    Hayashi T; Fukuzawa K; Kondo H; Onodera H; Tojo R; Yano S; Miyati T; Kotoku J; Okamoto T; Toyoda K; Oba H
    Radiol Phys Technol; 2018 Sep; 11(3):338-344. PubMed ID: 29858768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Gd-EOB-DTPA on proton density fat fraction using the six-echo Dixon method in 3 Tesla magnetic resonance imaging.
    Hayashi T; Fukuzawa K; Kondo H; Onodera H; Toyotaka S; Tojo R; Yano S; Tano M; Miyati T; Kotoku J; Okamoto T; Toyoda K; Oba H
    Radiol Phys Technol; 2017 Dec; 10(4):483-488. PubMed ID: 28895045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Gd-EOB-DTPA on hepatic fat quantification using high-speed T2-corrected multi-echo acquisition in (1)H MR spectroscopy.
    Park YS; Lee CH; Kim JH; Kim BH; Kim JH; Kim KA; Park CM
    Magn Reson Imaging; 2014 Sep; 32(7):886-90. PubMed ID: 24853467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.
    Zech CJ; Grazioli L; Breuer J; Reiser MF; Schoenberg SO
    Invest Radiol; 2008 Jul; 43(7):504-11. PubMed ID: 18580333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phantom and animal studies of a new hepatobiliary agent for MR imaging: comparison of Gd-DTPA-DeA with Gd-EOB-DTPA.
    Yoshikawa K; Inoue Y; Akahane M; Shimada M; Itoh S; Seno A; Hayashi S
    J Magn Reson Imaging; 2003 Aug; 18(2):204-9. PubMed ID: 12884333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging.
    Katsube T; Okada M; Kumano S; Hori M; Imaoka I; Ishii K; Kudo M; Kitagaki H; Murakami T
    Invest Radiol; 2011 Apr; 46(4):277-83. PubMed ID: 21343827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.
    Bluemke DA; Sahani D; Amendola M; Balzer T; Breuer J; Brown JJ; Casalino DD; Davis PL; Francis IR; Krinsky G; Lee FT; Lu D; Paulson EK; Schwartz LH; Siegelman ES; Small WC; Weber TM; Welber A; Shamsi K
    Radiology; 2005 Oct; 237(1):89-98. PubMed ID: 16126918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of liver proton density fat fraction and changes in R 2* measurements induced by administering gadoxetic acid at 3T MRI.
    Sofue K; Zhong X; Nickel MD; Dale BM; Bashir MR
    Abdom Radiol (NY); 2016 Aug; 41(8):1555-64. PubMed ID: 27052456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging.
    Tsuda N; Okada M; Murakami T
    Invest Radiol; 2007 Apr; 42(4):242-7. PubMed ID: 17351431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging of fat-containing tissues: valuation of two quantitative imaging techniques in comparison with localized proton spectroscopy.
    Brix G; Heiland S; Bellemann ME; Koch T; Lorenz WJ
    Magn Reson Imaging; 1993; 11(7):977-91. PubMed ID: 8231682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
    Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
    J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
    Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J
    Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multisite, multivendor validation of the accuracy and reproducibility of proton-density fat-fraction quantification at 1.5T and 3T using a fat-water phantom.
    Hernando D; Sharma SD; Aliyari Ghasabeh M; Alvis BD; Arora SS; Hamilton G; Pan L; Shaffer JM; Sofue K; Szeverenyi NM; Welch EB; Yuan Q; Bashir MR; Kamel IR; Rice MJ; Sirlin CB; Yokoo T; Reeder SB
    Magn Reson Med; 2017 Apr; 77(4):1516-1524. PubMed ID: 27080068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced MR angiography in rats with hepatobiliary contrast agents.
    Yoshikawa K; Inoue Y; Shimada M; Akahane M; Itoh S; Seno A; Hayashi S
    Magn Reson Imaging; 2004 Sep; 22(7):937-42. PubMed ID: 15288134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gd-EOB-DTPA and Yb-EOB-DTPA: two prototypic contrast media for CT detection of liver lesions in dogs.
    Schmitz SA; Wagner S; Schuhmann-Giampieri G; Krause W; Bollow M; Wolf KJ
    Radiology; 1997 Nov; 205(2):361-6. PubMed ID: 9356615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Gd-EOB-DTPA on proton-density fat fraction in the liver using chemical shift-encoded magnetic resonance imaging at 3-T.
    Suzuki M; Hayashi T; Nashiki K; Kawata H; Nagata S; Abe T
    Radiol Phys Technol; 2024 May; ():. PubMed ID: 38730134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
    Chen CY; Chen J; Xia CC; Huang ZX; Song B
    J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radial MRI during free breathing in contrast-enhanced hepatobiliary phase imaging.
    Gomi T; Nagamoto M; Hasegawa M; Tabata A; Iwasaki M; Ooka M; Murata N; Tsunoo M; Iizuka Y; Kohda E; Shiraga N
    Acta Radiol; 2014 Feb; 55(1):3-7. PubMed ID: 23873886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter, multivendor phantom study to validate proton density fat fraction and T2* values calculated using vendor-provided 6-point DIXON methods.
    Hayashi T; Fukuzawa K; Yamazaki H; Konno T; Miyati T; Kotoku J; Oba H; Kondo H; Toyoda K; Saitoh S
    Clin Imaging; 2018; 51():38-42. PubMed ID: 29425901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.